Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Arm & Hammer Peroxicare

This article was originally published in The Tan Sheet

Executive Summary

Arm & Hammer Peroxicare: New TV ads for the Church & Dwight toothpaste breaking the week of April 20 convey product benefits through "thought" bubbles. A spokeswoman says to "forget" other toothpastes, while tubes of Chesebrough-Pond's Mentadent and Colgate-Palmolive's Colgate float above her head in a bubble. "I've got the zing of Arm & Hammer Peroxicare!" A voice-over proclaims: "It's today's most potent baking soda and peroxide toothpaste. Because it has the most baking soda cleaning power." A superimposed message notes the product has "50% baking soda content." New TV ads breaking for the company's Dental Care toothpaste claim the product cleans away plaque "better than regular toothpastes" based on a "comparison of leading regular paste products." The "patented baking soda formula cleans the surface, then gets in tiny crevices to remove ugly stains," the ad says. Both ads were developed in-house...

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS088369

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel